What causes hhv8

What is Human Herpesvirus 8 (HHV-8)?

Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is a member of the gammaherpesvirus subfamily. This virus is known to cause several types of cancers, most notably Kaposi's sarcoma (KS), which is a cancer that develops from the cells that line lymph or blood vessels. HHV-8 is also associated with primary effusion lymphoma (PEL), a rare type of non-Hodgkin lymphoma, and multicentric Castleman disease (MCD), a rare lymphoproliferative disorder.

How is HHV-8 Transmitted?

The transmission routes of HHV-8 are varied, but understanding them is crucial for prevention. The primary modes of transmission are:

Sexual Transmission

Sexual contact is considered the most common route of HHV-8 transmission, particularly among homosexual and bisexual men. This includes intimate contact such as oral, anal, and vaginal sex. The virus can be present in semen, vaginal fluids, and saliva, making sexual activity a significant risk factor for infection.

Saliva Transmission

HHV-8 can also be transmitted through saliva. This can occur through close personal contact, such as kissing or sharing utensils, although this mode of transmission is generally considered less efficient than sexual contact for developing symptomatic disease. However, prolonged or intense exposure to infected saliva may increase the risk.

Blood and Body Fluid Transmission

Transmission through blood and other body fluids is also possible. This can happen through sharing contaminated needles, particularly among intravenous drug users, or through blood transfusions, although the latter is rare due to screening measures. Accidental exposure to infected blood, such as through needlestick injuries in healthcare settings, can also pose a risk.

Vertical Transmission

While less common, there is evidence suggesting that HHV-8 can be transmitted from an infected mother to her child during pregnancy (vertical transmission) or during childbirth. However, the exact mechanisms and incidence of this transmission route are still being researched.

Risk Factors for HHV-8 Infection and Disease

While many people infected with HHV-8 never develop symptoms or related diseases, certain factors increase the risk of developing Kaposi's sarcoma and other HHV-8-associated conditions:

• Immunocompromise: The most significant risk factor for developing symptomatic HHV-8 disease is a weakened immune system. This is particularly seen in individuals with advanced HIV/AIDS, organ transplant recipients taking immunosuppressive drugs, and individuals with other conditions that impair immune function. The compromised immune system allows the virus to replicate more freely and lead to cancer development.
• Age: While infection can occur at any age, the development of symptomatic disease, like Kaposi's sarcoma, is more common in older adults.
• Geographic Location: HHV-8 is more prevalent in certain parts of the world, including regions around the Mediterranean, sub-Saharan Africa, and areas with large homosexual populations. This suggests a higher baseline prevalence in these areas, leading to more opportunities for transmission.
• Socioeconomic Factors: Some studies suggest that lower socioeconomic status and crowded living conditions might be associated with higher rates of HHV-8 infection due to increased opportunities for close contact and transmission.

Symptoms of HHV-8 Infection and Associated Diseases

Most individuals infected with HHV-8 remain asymptomatic throughout their lives. The virus can remain dormant in the body for years. When symptoms do appear, they are typically related to the cancers or conditions caused by the virus:

• Kaposi's Sarcoma (KS): This is the most common manifestation. KS appears as purplish, red, or brown lesions on the skin, mucous membranes (like in the mouth), lymph nodes, or other organs. In individuals with weakened immune systems, KS can be widespread and aggressive.
• Primary Effusion Lymphoma (PEL): This is a type of lymphoma that occurs in the fluid-filled spaces of the body, such as the chest cavity or abdomen. It is aggressive and often difficult to treat.
• Multicentric Castleman Disease (MCD): This condition involves widespread enlargement of lymph nodes throughout the body, accompanied by systemic symptoms like fever, night sweats, weight loss, and fatigue.

Diagnosis and Treatment

Diagnosing HHV-8 infection often involves detecting the virus or antibodies against it using blood tests. For associated cancers, diagnosis relies on biopsies of the affected tissues. Treatment for HHV-8 itself is not typically necessary unless symptoms or related diseases develop. Treatment focuses on managing the specific condition, such as chemotherapy for lymphomas or radiation therapy for Kaposi's sarcoma. For individuals with HIV/AIDS, highly active antiretroviral therapy (HAART) is crucial as it strengthens the immune system, which can help control HHV-8 and reduce the risk of KS development.

Prevention

Preventing HHV-8 infection primarily involves reducing exposure to the virus. Safe sex practices, including the consistent use of condoms, are recommended. Avoiding the sharing of needles and personal items like razors and toothbrushes can also help prevent transmission. For individuals with compromised immune systems, maintaining good overall health and adhering to medical advice is important.